John D. Ash was awarded three year grant titled: “Using AAV-STAT3 and AAV-PIM-1 vectors to induce broad-spectrum protection of photoreceptors and PRE” from the Foundation Fighting Blindness. This project has the potential to lead to therapeutics to preserve photoreceptors and RPE in a large number of patients of retinal degeneration and dry AMD.